Browne M J, Moss M Y, Boyd M R
Antimicrob Agents Chemother. 1983 Mar;23(3):503-5. doi: 10.1128/AAC.23.3.503.
The activities of amantadine and ribavirin against influenza A viruses were compared against low-multiplicity (plaque inhibition) and high-multiplicity (protein synthesis inhibition) infections. Our results suggest that the predictive value of in vitro data for the clinic may be improved by consideration of tests against a high-multiplicity infection.
比较了金刚烷胺和利巴韦林对甲型流感病毒在低 multiplicity(蚀斑抑制)和高 multiplicity(蛋白质合成抑制)感染情况下的活性。我们的结果表明,通过考虑针对高 multiplicity 感染的测试,体外数据对临床的预测价值可能会得到提高。